Michael Okun

Human trial of closed-loop DBS in four participants with difficult-to-treat Tourette syndrome finds treatment to be safe, beneficial.

Study co-led by Dr. Michael Okun used temporally optimized patterned stimulation, or TOPS, as a therapy to personalize DBS treatment for Parkinson’s.

Drs. Justin Hilliard and Michael Okun featured in UF Health Inspire video about twin sisters treated for essential tremor.

International panel of experts co-led by Dr. Michael Okun says action is needed to improve certain patients’ quality of life.

Dr. Michael Okun co-authored JAMA Neurology special communication stemming from WHO consultation workshop.

Discovery of protein changes in blood immune cells could pave the way for a simple screening test for Parkinson’s diagnosis.

Dr. Michael Okun weighs in on mouse-model study reporting that COVID-19 infection increased risk of Parkinson’s in mice.

UF neurosurgery No. 4 overall and neuroscience/neurology departments No. 5 among public universities in Blue Ridge Institute rankings.

Drs. Adolfo Ramirez-Zamora and Michael Okun served as editors for special edition.

Findings lay groundwork for development of a blood test that could be used to help diagnose, treat Parkinson’s disease.